NEW YORK (Reuters) - AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection